DOSAGE THÉRAPEUTIQUE D'UNE NEURÉGULINE DANS LE TRAITEMENT OU LA PROPHYLAXIE DE L'INSUFFISANCE CARDIAQUE

• 收藏
• 分享

专利权人:

Acorda Therapeutics; Inc.

发明人:

申请号：

EP17209369.2

公开号：

EP3338791B1

申请日:

2009.07.17

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/